Key research findings using the GLYVAR® Ovarian Assay
The data is from a recent peer-reviewed publication in Clinical Chemistry and Laboratory Medicine, which highlights the technical features of GLYVAR® Ovarian Assay and underscores the potential of glycovariant approach in ovarian cancer research.
Read more about the science behind the GLYVAR® Ovarian Assay
- Advanced glycosylation-based test: The study demonstrated a markedly enhanced separation of sample groups compared with conventional CA125–based protein measurements, particularly in samples with marginally elevated CA125 levels and early‑stage disease samples.
- Improved differentiation: Detection of glycosylation patterns showed clear differences between malignant and non‑malignant conditions, including benign tumours and endometriosis, supporting further use of this approach in ovarian cancer–related research.
- Accessible technology: Compatible with standard laboratory equipment making it suitable for a wide range of settings.
For Research Use Only. Not For Use in Diagnostic Procedures.
Conformity assessment by a notified body for CE marked medical device use under EU IVDR planned for 2027.
Brochures
